[CHRS] QoQ Quarter Result on 30-Sep-2016 [#Q3]

Stock
[CHRS] Coherus BioSciences, Inc.
Announcement Date
09-Nov-2016
Financial Year
2016
Quarter
30-Sep-2016 [#Q3]
Profit Trend
QoQ- 219.97%
YoY- 217.67%
Quarter Report
CHRS's Result
CHRS's Financial Summary
View:
Show?
Quarter Result
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Revenue 1,395 161 844 162,835 14,068 12,359 10,198 -73.48%
PBT -55,402 -74,822 -75,944 83,844 -70,150 -65,538 -52,580 3.55%
Tax 5,938 2,303 428 3,972 -2,889 338 489 429.11%
NP -55,336 -74,778 -75,921 83,939 -69,967 -65,388 -52,391 3.71%
Tax Rate - - - -4.74% - - - -
Total Cost 56,731 74,939 76,765 78,896 84,035 77,747 62,589 -6.34%
Ratio Analysis
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
NP Margin -3,966.74 -46,445.96 -8,995.38 51.55 -497.35 -529.07 -513.74 291.14%
Per Share
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
EPS -1.08 -1.54 -1.71 1.93 -1.72 -1.67 -1.35 -13.83%
EPS Diluted -1.08 -1.54 -1.71 1.67 -1.72 -1.67 -1.35 -13.83%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.